Are you more inclined to offer adjuvant chemotherapy for a post-menopausal woman after lumpectomy for a small TNBC who has a concurrent metastatic ER+ breast CA?  

Any difference in recommendations if the patient was asymptomatic from her metastatic ER+ disease? (eg bone mets)



Answer from: Medical Oncologist at Academic Institution